亨迪药业(301211.SZ)：目前公司出口日本业务收入占整体营业收入的比例不足1%

Core Viewpoint - Hendi Pharmaceutical (301211.SZ) has registered its ibuprofen raw material for export to Japan, which currently contributes less than 1% of the company's total revenue, thus not significantly impacting its overall performance [1] Group 1 - The company has obtained export qualifications for ibuprofen raw materials to Japan [1] - The revenue from the export business to Japan is currently minimal, accounting for less than 1% of total revenue [1] - The registration in Japan indicates potential for future growth in international markets [1]